(ATHN) - Get Report

downgraded at Baird to Neutral. Valuation call, as the stock is up more than 40% over the past month.

Baker Hughes


upgraded at Susquehanna. BHI was upgraded from Neutral to Positive. $53 price target. Recent pullback has created a buying opportunity in the potential turnaround play.

Cooper Industries

( CBE) rated new Buy at Deutsche Bank. $60 price target. Company is a pure-play in electrical equipment and can grow its margins in the new order cycle. Buy rating.

CF Industries

(CF) - Get Report

upgraded at Goldman from Neutral to Buy. Stock was also added to the Conviction List, with a $110 price target. Company should benefit from growth in the nitrogen and phosphate markets.

Canadian National

(CN) - Get Report

initiated at Barclays. CN initiated with an Equal Weight rating and $70 price target. CN is the most profitable of North America railroads and well positioned to capitalize on recovery.



upgraded at Stifel from Hold to Buy. $36 price target. Stock appears oversold, following the 20% post-earnings selloff.

Canadian Pacific Railway

(CP) - Get Report

initiated at Barclays with an Equal Weight rating and C$68 price target. Several factors leave CP less profitable then industry.

Dollar Tree

(DLTR) - Get Report

downgraded at JP Morgan. DLTR was downgraded from Neutral to Underweight. Valuation call, as the stock has more than doubled since the beginning of 2008.

JB Hunt

(JBHT) - Get Report

upgraded at Stifel from Hold to Buy. $40 price target. Stock is down 17% over the past four months, even though the company had a good quarter.

New Gold

(NGD) - Get Report

initiated at BofA/Merrill. NGD coverage initiated at Bank of America/Merrill Lynch with a Buy rating and C$7.65 price target. Solid gold production growth and improving cash costs.



downgraded at BMO from Outperform to Market Perform. Valuation call, based on a $17 price target.


(TGT) - Get Report

upgraded at BofA/Merrill to Buy from Neutral as momentum could improve given increasing support from P-Fresh store conversions. Price target increased to $61 from $56.


(UGI) - Get Report

upgraded at BMO to Outperform. $33 price target. Company is positioned well for solid earnings over the new few years.


(VAL) - Get Report

downgraded at Goldman from Buy to Neutral. Company is seeing lower paint demand and being hurt by higher raw material costs. $33 price target.


Agilent Technologies

(A) - Get Report

price target decreased at Credit Suisse to $36 from $40. Solid 3Q10 results, EMG segment is not seeing a slowdown in any end markets or geographies. Maintain Outperform rating.

Agilent Technologies

(A) - Get Report

estimates increased at Jefferies through 2012. Company has significant operating leverage. Buy rating and $42 price target.

Baker Hughes


price target lower at Barclays. BHI price target trimmed to $43 from $46. International margins remain weak. Reiterate Equal Weight rating.


(BRKR) - Get Report

estimates, target raised at Jefferies. Shares of BRKR now seen reaching $15.50. Estimates also increased, as the company should benefit from stimulus initiatives across the globe. Hold rating.


(CCL) - Get Report

estimates, target increased at Goldman. CCL estimates were raised through 2012. Company is seeing lower fuel prices. Neutral rating and new $36 price target.

Consol Energy

(CNX) - Get Report

numbers cut at UBS. Shares of CNX now seen reaching $67. Estimates also lowered, given lower expected natural gas prices. Buy rating.

(CRM) - Get Report

price target boosted at BofA/Merrill. CRM price target raised to $120 from $100. Improvement in business ton and better bookings. Reiterate Buy rating.

Education Management


numbers cut at Goldman. Shares of EDMC now seen reaching $10. Estimates also lowered, given lower loan repayment rates. Neutral rating.


(INTU) - Get Report

price target raised at BofA/Merrill to $44 from $39. Expecting strong 4Q10 results. Maintain Buy rating.


(KEY) - Get Report

price target lower at Credit Suisse by a dollar to $10. Credit quality prospects positive but loan demand remains low. Maintain Outperform rating.


(LOW) - Get Report

estimates, target raised at Citigroup. Shares of LOW now seen reaching $22. Estimates also increased, given higher realized margins. Hold rating.


(LOW) - Get Report

estimates upped at Jefferies. LOW estimates were boosted through 2012. Management is realizing higher margins, despite softer sales. Buy rating and $24 price target.

Medco Health Solutions


price target cut at BofA/Merrill to $70 from $74 as the company acquires United BioSource. Maintain Buy rating.


(NFLX) - Get Report

estimates reduced at Morgan Stanley. NFLX estimates were cut through 2012. EPIX deal could pressure margins, but still makes strategic sense. Overweight rating.

Smith International

( SII) price target boosted at Barclays. SII price target increased to $56 from $52 as earnings estimates improve. 2010 and 2011 EPS estimates lifted to $1.15 and $1.65, respectively. Maintain Equal Weight rating.

Urban Outfitters

(URBN) - Get Report

estimates boosted at UBS. URBN estimates were upped through 2012. Company is executing well in a choppy environment. Buy rating and $45 price target.

Urban Outfitters

(URBN) - Get Report

target lowered at Piper. Shares of URBN now seen reaching $35. Core stores are lagging the other concepts and management has limited sales visibility. Neutral rating.

This article was written by a staff member of TheStreet.